|
⚲
|
| Keyboard |
| CL Alaska LP
✚
|
|
|---|---|
| CIK # | 0001626595 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001626595] | |
| 4 | [0001626595] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Crestline Management LP | |
| Bratton Douglas K | |
| CL Alaska LP | |
| Crestline Investors Inc | |
| Crestline SI GP LP | |
| Juno Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Juno Therapeutics Inc JUNO
Common Stock
|
2017-07-13 | Sell | 8,000,000 | $27.00 | 216,000,000 |
|
Juno Therapeutics Inc JUNO
Common Stock
|
2016-03-01 | Sell | 8,600,000 | $39.00 | 335,400,000 |
|
Juno Therapeutics Inc JUNO
Common Stock
|
2014-12-23 | Conversion | 13,750,000 | ||
|
Juno Therapeutics Inc JUNO
Common Stock
|
2014-12-23 | Conversion | 68,395 | ||
|
Juno Therapeutics Inc JUNO
Common Stock
|
2014-12-23 | Conversion | 2,277,732 | ||
|
Juno Therapeutics Inc JUNO
Common Stock
|
2014-12-23 | Conversion | 1,250,000 | ||
|
Juno Therapeutics Inc JUNO
Series B Preferred Stock · derivative
|
2014-12-23 | Conversion | 2,277,732 | ||
|
Juno Therapeutics Inc JUNO
Series A-2 Preferred Stock · derivative
|
2014-12-23 | Conversion | 1,250,000 | ||
|
Juno Therapeutics Inc JUNO
Series B Preferred Stock · derivative
|
2014-12-23 | Conversion | 68,395 | ||
|
Juno Therapeutics Inc JUNO
Series A Preferred Stock · derivative
|
2014-12-23 | Conversion | 13,750,000 | ||
|
Juno Therapeutics Inc JUNO
Series A-2 Preferred Stock · derivative
|
2014-12-23 | Conversion | 8,750,000 | ||
|
Juno Therapeutics Inc JUNO
Common Stock
|
2014-12-23 | Conversion | 8,750,000 | ||
|
Juno Therapeutics Inc JUNO
Common Stock
|
2014-12-19 | Buy | 625,000 | $25.00 | 15,625,000 |